Want to see IL:CANF full AI Analyst Report?
Can Fite Bio (CANF) Stock Statistics & Valuation Metrics
Total Valuation
Can Fite Bio has a market cap or net worth of ILA 15.98M. The enterprise value is -ILA 5.67M.
- Market Cap
- ILA 15.98M
- Enterprise Value
- -ILA 5.67M
Share Statistics
Can Fite Bio has 6,070,627 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 6,070,627
- Owned by Insiders
- ―
- Owned by Institutions
- ―
Financial Efficiency
Can Fite Bio’s return on equity (ROE) is -1.90 and return on invested capital (ROIC) is -157.46%.
- Return on Equity (ROE)
- -1.90
- Return on Assets (ROA)
- -1.12
- Return on Invested Capital (ROIC)
- -157.46%
- Return on Capital Employed (ROCE)
- -1.59
- Revenue Per Employee
- 87.68K
- Profits Per Employee
- -2.13M
- Employee Count
- 5
- Asset Turnover
- 0.05
- Inventory Turnover
- 0.00
Valuation Ratios
The current PE Ratio of Can Fite Bio is -0.24. Can Fite Bio’s PEG ratio is 0.00.
- PE Ratio
- -0.24
- PS Ratio
- 8.87
- PB Ratio
- 0.64
- Price to FCF
- -0.38
- Price to Operating Cash Flow
- -0.33
- PEG Ratio
- 0.00
Income Statement
In the last 12 months, Can Fite Bio had revenue of 438.40K and earned -10.64M in profits. Earnings per share was -6.46.
- Revenue
- 438.40K
- Gross Profit
- 412.42K
- Operating Income
- -10.77M
- Pretax Income
- -10.64M
- Net Income
- -10.64M
- EBITDA
- -10.74M
- Earnings Per Share (EPS)
- -6.46
Cash Flow
In the last 12 months, operating cash flow was -9.51M and capital expenditures -2,000, giving a free cash flow of -9.51M billion.
- Operating Cash Flow
- -9.51M
- Free Cash Flow
- -9.51M
- Free Cash Flow per Share
- -2.56
Dividends & Yields
Can Fite Bio pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- -264.81%
- Earnings Yield
- -307.06%
Stock Price Statistics
- Beta
- -0.47
- 52-Week Price Change
- -91.22%
- 50-Day Moving Average
- 375.97
- 200-Day Moving Average
- 526.77
- Relative Strength Index (RSI)
- 16.54
- Average Volume (3m)
- 19.27K
Important Dates
Can Fite Bio upcoming earnings date is Apr 01, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Sep 08, 2026
- Next Earnings Date
- Apr 01, 2027
- Ex-Dividend Date
- ―
Financial Position
Can Fite Bio as a current ratio of 3.46, with Debt / Equity ratio of 1.27%
- Current Ratio
- 3.46
- Quick Ratio
- 3.46
- Debt to Market Cap
- 0.00
- Net Debt to EBITDA
- 0.51
- Interest Coverage Ratio
- -710.74
Taxes
In the past 12 months, Can Fite Bio has paid 0 in taxes.
- Income Tax
- 0
- Effective Tax Rate
- 0.00
Enterprise Valuation
Can Fite Bio EV to EBITDA ratio is -0.07, with an EV/FCF ratio of -0.07.
- EV to Sales
- 1.62
- EV to EBITDA
- -0.07
- EV to Free Cash Flow
- -0.07
- EV to Operating Cash Flow
- -0.07
Balance Sheet
Can Fite Bio has ILA 7.04M in cash and marketable securities with ILA 49.00K in debt, giving a net cash position of ILA 6.99M billion.
- Cash & Marketable Securities
- ILA 7.04M
- Total Debt
- ILA 49.00K
- Net Cash
- ILA 6.99M
- Net Cash Per Share
- ILA 1.15
- Tangible Book Value Per Share
- ILA 1.31
Margins
Gross margin is 100.00%, with operating margin of -2402.96%, and net profit margin of -2358.77%.
- Gross Margin
- 100.00%
- Operating Margin
- -2402.96%
- Pretax Margin
- -2358.77%
- Net Profit Margin
- -2358.77%
- EBITDA Margin
- -2402.47%
- EBIT Margin
- -2402.96%
Scores
- Smart Score
- ―
- AI Score
- 40